U.S. set to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents

Download

The U.S. Food and Drug Administration is preparing to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans.

Open in CGTN APP for better experience

Search Trends